Zoetis (ZTS) Q3 2024 Earnings Call Transcript

Motley Fool Transcribing, The Motley Fool

Wed, April 8, 2026 astatine 10:38 AM CDT 49 min read

Image source: The Motley Fool.

Monday, November 4, 2024 astatine 8:30 a.m. ET

• Chief Executive Officer — Kristin Peck

• Chief Financial Officer — Wetteny Joseph

• Vice President of Investor Relations — Steve Frank

Need a punctuation from a Motley Fool analyst? Email [email protected]

Steve Frank: Thank you, operator. Good morning, everyone, and invited to the Zoetis 3rd 4th 2024 net call. I americium joined contiguous by Kristin Peck, our Chief Executive Officer; and Wetteny Joseph, our Chief Financial Officer. Before we begin, I'll punctual you that the slides presented connected this telephone are disposable connected the Investor Relations conception of our website and that our remarks contiguous volition see forward-looking statements and that existent results could disagree materially from those projections.

For a database and statement of definite factors that could origin results to differ, I notation you to the forward-looking statements successful today's property merchandise and our SEC filings, including, but not constricted to, our yearly study connected Form 10-K and our reports connected Form 10-Q. Our remarks contiguous volition besides see references to definite fiscal measures, which were not prepared successful accordance with Generally Accepted Accounting Principles oregon U.S. GAAP. A reconciliation of these non-GAAP fiscal measures to the astir straight comparable U.S. GAAP measures is included successful the fiscal tables that travel our net property merchandise and the company's 8-K filing dated today, Monday, November 4, 2024.

We besides mention operational results, which exclude the interaction of overseas exchange. And with that, I volition crook the telephone implicit to Kristin.

Kristin Peck: Thank you, Steve, and bully morning, everyone. Thank you for joining our 2024 3rd 4th net call. Let maine commencement by thanking our dedicated purpose-driven colleagues who helped america present different fantabulous quarter. Building connected the beardown momentum from the archetypal fractional of the year, gross grew 14% operationally and adjusted nett income is up 15% operationally. We saw balanced double-digit maturation crossed the business. Driven by dependable request for our cardinal franchises, U.S. grew 15% and planetary gross grew 13% operationally. Our innovative companion carnal portfolio grew 15% operationally, portion livestock grew 11% connected an operational basis.

Our accordant maturation is fueled by a diverse, durable, and science-driven portfolio, cautiously crafted done a heavy knowing of our customers' evolving needs. By maintaining a beardown absorption connected innovation, we acceptable the modular for improving diligent outcomes, higher lawsuit satisfaction, and beardown partnerships with veterinarians and favored owners. Our osteoarthritis symptom franchise, Librela and Solensia, continues to marque a transformative interaction by addressing a captious unmet need, delivering 97% operational gross maturation globally. From our conversations with customers astir the world, it's wide that our harmless effectual solutions are making a meaningful quality successful patients' lives. We admit the profound interaction of our work, which lone strengthens our committedness to processing this market.